Patents by Inventor Rajeev Chillakuru

Rajeev Chillakuru has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods related to cell surface glycosylation
    Patent number: 8338088
    Abstract: The present disclosure provides methods for assessing the glycosylation of a target glycoprotein produced by a cell through analysis of cell-surface glycans on the cell. The present disclosure therefore teaches that glycosylation of cell surface proteins can serve as a proxy for glycosylation of other proteins.
    Type: Grant
    Filed: April 15, 2008
    Date of Patent: December 25, 2012
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Brian Edward Collins, Carlos J. Bosques, Xiangping Zhu, Dorota A. Bulik, Lakshmanan Thiruneelakantapillai, Ian Christopher Parsons, Zachary Shriver, Rajeev Chillakuru, Ganesh Venkataraman
  • METHODS RELATED TO CELL SURFACE GLYCOSYLATION
    Publication number: 20100196940
    Abstract: The present disclosure provides methods for assessing the glycosylation of a target glycoprotein produced by a cell through analysis of cell-surface glycans on the cell. The present disclosure therefore teaches that glycosylation of cell surface proteins can serve as a proxy for glycosylation of other proteins.
    Type: Application
    Filed: April 15, 2008
    Publication date: August 5, 2010
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Brian Edward Collins, Carlos J. Bosques, Xiangping Zhu, Dorota A. Bulik, Lakshmanan Thiruneelakantapillai, Ian Christopher Parsons, Zachary Shriver, Rajeev Chillakuru, Ganesh Venkataraman
  • DEFINED GLYCOPROTEIN PRODUCTS AND RELATED METHODS
    Publication number: 20100113294
    Abstract: The invention provides methods, databases and systems for making glycoprotein products having defined properties.
    Type: Application
    Filed: April 15, 2008
    Publication date: May 6, 2010
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Ganesh Venkataraman, Brian Edward Collins, Carlos J. Bosques, Lakshmanan Thiruneelakantapillai, Dorota A. Bulik, Ian Christopher Parsons, Zachary Shriver, Rajeev Chillakuru
  • Formulations and methods of production of FGF-20
    Publication number: 20060094651
    Abstract: The present invention provides improved formulations comprising FGF-20, its fragments, derivatives, variants, homologs, analogs, or a combination thereof, and improved methods for production.
    Type: Application
    Filed: November 3, 2004
    Publication date: May 4, 2006
    Inventors: Cyrus Karkaria, Tracy Chen, Rajeev Chillakuru, Gan Wei, Saravanamoorthy Rajendran
  • Methods of preventing and treating alimentary mucositis
    Publication number: 20050256042
    Abstract: The present invention relates to compositions and methods for preventing and treating alimentary mucositis. More particularly, the present invention provides methods for preventing and/or treating alimetary mucositis by using compositions comprising FGF-20, a fragment, a derivative, a variant, a homolog, or an analog thereof.
    Type: Application
    Filed: November 3, 2004
    Publication date: November 17, 2005
    Inventors: Michael Jeffers, Zachary Yim, Pascal Valax, Pradyumna Namdev, Rajeev Chillakuru, William LaRochelle, Henri Lichenstein, Enrique Alvarez, William Hahne
  • Compositions and methods of use for a fibroblast growth factor
    Publication number: 20040214759
    Abstract: In methods of using a fibroblast growth factor, such as for treating, preventing or delaying a proliferation-associated disorder, steps are provided to administer to a subject a therapeutically effective amount of a particular fibroblast growth factor polypeptide, or variant or fragment thereof.
    Type: Application
    Filed: May 9, 2003
    Publication date: October 28, 2004
    Inventors: John P. Alsobrook, Enrique Alvarez, David W. Anderson, Joel S. Bader, Ferenc L. Boldog, Catherine E. Burgess, Rajeev A. Chillakuru, Lisa Deegler, Shlomit R. Edinger, Elma R. Fernandes, Linda Gorman, William M. Grosse, John L. Herrmann, Michael E. Jeffers, William J. LaRochelle, Denise M. Lepley, Henri S. Lichenstein, Kumar Namdev, Muralidhara Padigaru, Carol E. A. Pena, Sudhirdas K. Prayaga, Daniel K. Rieger, Richard A. Shimkets, Pascal Valax, Meijia Yang, Zachary Yim, Mei Zhong
  • Therapeutic polypeptides, nucleic acids encoding same, and methods of use
    Publication number: 20040023241
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: December 2, 2002
    Publication date: February 5, 2004
    Inventors: John P. Alsobrook, David W. Anderson, Ferenc L. Boldog, Catherine E. Burgess, Rajeev A. Chillakuru, Shlomit R. Edinger, Valerie Gerlach, Linda Gorman, Bonnie Gould-Rothberg, Xiaojia Sasha Guo, Michael E. Jeffers, Weizhen Ji, Li Li, Uriel M. Malyankar, Charles E. Miller, Ryan Murphey, Meera Patturajan, John A. Peyman, Luca Rastelli, Daniel K. Rieger, Suresh G. Shenoy, Glennda Smithson, Gary Starling, Raymond J. Taupier, Edward Z. Voss, Haihong Zhong, Mei Zhong